TP53 and breast cancer: Mechanistically, protein overexpression of mdm2 (which is typically due to a corresponding gain of gene copies) and enhanced mdm2 activity causes a pronounced p53 ubiquitination that results in the degradation of this prominent and, in BC, relevant tumor suppressor.